AstraZeneca Aktie
160,55
EUR
-0,90
EUR
-0,56
%
138,48
GBP
-1,02
GBP
-0,73
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 160,00 GBP | - | 14.05.2026 | |
| Jefferies & Company Inc. | 180,00 GBP | - | 13.05.2026 | |
| Bernstein Research | 186,00 GBP | - | 04.05.2026 | |
| Deutsche Bank AG | 115,00 GBP | - | 30.04.2026 | |
| DZ BANK | - | - | 29.04.2026 | |
| Barclays Capital | 165,00 GBP | - | 29.04.2026 | |
| UBS AG | 176,00 GBP | - | 10.04.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 170,00 GBP | - | 16.03.2026 | |
| Goldman Sachs Group Inc. | 163,89 GBP | - | 28.01.2026 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 8 | 0 | 1 | 164,49 GBP | - |
| Bayer | 6 | 4 | 0 | 42,44 EUR | +9,52% |
| BioNTech (ADRs) | 4 | 0 | 0 | 137,50 USD | +52,17% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 1 | 0 | 8,07 EUR | +59,01% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 4 | 2 | 0 | 140,40 EUR | +11,78% |
| Moderna Inc | 0 | 1 | 0 | 45,00 USD | -6,48% |
| Novartis AG | 2 | 6 | 1 | 119,62 CHF | +0,86% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 2 | 5 | 0 | 28,83 USD | +11,79% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Roche Holding AG Inhaber-Partizipationsschein | 4 | 4 | 1 | - | - |
| Sanofi S.A. | 4 | 4 | 0 | 96,12 EUR | +23,79% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |




